Article in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Despoina Varamogianni-MamatsiHellenic Centre for Marine Research, Institute of Marine Biology, Biotechnology and Aquaculture, 71500 Heraklion Crete, Greece.
Maria João NunesLAQV, REQUIMTE, Associated Laboratory for Green Chemistry, Chemistry Department, NOVA School of Science and Technology, NOVA University of Lisbon, Campus Caparica, 2819-516 Caparica, Portugal.ORCID 0000-0002-4378-5173
Vanda MarquesResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisboa, Portugal.ORCID 0000-0003-3515-0781
Thekla I AnastasiouHellenic Centre for Marine Research, Institute of Marine Biology, Biotechnology and Aquaculture, 71500 Heraklion Crete, Greece.
Eirini KagiampakiHellenic Centre for Marine Research, Institute of Marine Biology, Biotechnology and Aquaculture, 71500 Heraklion Crete, Greece.
Emmanouela VernadouHellenic Centre for Marine Research, Institute of Marine Biology, Biotechnology and Aquaculture, 71500 Heraklion Crete, Greece.
Thanos DailianisHellenic Centre for Marine Research, Institute of Marine Biology, Biotechnology and Aquaculture, 71500 Heraklion Crete, Greece.ORCID 0000-0002-4102-9331
Nicolas KalogerakisSchool of Chemical and Environmental Engineering, Technical University of Crete, 73100 Chania, Greece.ORCID 0000-0001-7033-0302
Luís C BrancoLAQV, REQUIMTE, Associated Laboratory for Green Chemistry, Chemistry Department, NOVA School of Science and Technology, NOVA University of Lisbon, Campus Caparica, 2819-516 Caparica, Portugal.ORCID 0000-0003-2520-1151
Cecília M P RodriguesResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Professor Gama Pinto, 1649-003 Lisboa, Portugal.ORCID 0000-0002-4829-754X
Rita G SobralAssociate Laboratory i4HB, Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University of Lisbon, Campus Caparica, 2819-516 Caparica, Portugal.ORCID 0000-0003-4533-7531
Susana P GaudêncioAssociate Laboratory i4HB, Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University of Lisbon, Campus Caparica, 2819-516 Caparica, Portugal.ORCID 0000-0002-5510-1170
Manolis MandalakisHellenic Centre for Marine Research, Institute of Marine Biology, Biotechnology and Aquaculture, 71500 Heraklion Crete, Greece.ORCID 0000-0002-7469-4290
Funding
European Cooperation in Science and Technology EU-COST COST Action CA18238 (Ocean4Biotech)FARM-ID - Faculty of Pharmacy Research and Development Association LCF/PR/HR21/52410028FARM-ID - Faculty of Pharmacy Research and Development Association PTDC/MED-FAR/3492/2021FCT-Fundação para a Ciência e a Tecnologia, IP LA/P/0140/2020FCT-Fundação para a Ciência e a Tecnologia, IP UIDB/50006/2020FCT-Fundação para a Ciência e a Tecnologia, IP UIDP/04378/2020FCT-Fundação para a Ciência e a Tecnologia, IP UIDP/50006/2020Hellenic Foundation for Research and Innovation No239
6 · The paper itself
Abstract
Marine sponges are highly efficient in removing organic pollutants and their cultivation, adjacent to fish farms, is increasingly considered as a strategy for improving seawater quality. Moreover, these invertebrates produce a plethora of bioactive metabolites, which could translate into an extra profit for the aquaculture sector. Here, we investigated the chemical profile and bioactivity of two Mediterranean species (i.e.,
Indexed as
AgelasAnti-Infective AgentsMethicillin-Resistant Staphylococcus aureusPoriferaAnimalsAnti-Bacterial AgentsHumansAnti-Bacterial AgentsAnti-Infective Agentsaquaculture and fish farmingbioactive compounds supplychemical fingerprintingdemospongiaemarine natural productsmarine sponge farmingMS/MS dereplicationporiferaprimary metabolitessecondary metabolites
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Comparative Chemical Profiling and Antimicrobial/Anticancer Evaluation of Extracts from Farmed versus Wild · full record | OpenQuestion